Premium – High Strength Quality Glucosamine Sulphate 2KCL Tablets – 1000mg x 90

£4.99

Content Goes Here

100 in stock

Description

UKHealthHouse

Glucosamine Sulphate 2KCL Tablets 1000mg

Benefits:

  • Glucosamine sulfate is taken by mouth for osteoarthritis.
  • May help in Glaucoma.
  • May help in Weight loss.
  • May help in Joint pain caused by drugs.
  • May help in jaw pain.
  • May help in joint pain.
  • May help in knee pain.
  • May help in back pain.
  • May help in multiple sclerosis.

Ingredients:

Active Ingredient:

Glucosamine Sulphate 2KCl – providing Glucosamine Sulphate – 750mg of which Glucosamine – 592mg, Glucosamine Sulphate 2KCl (crustaceans), Maltodextrin, Microcrystalline Cellulose, Polyvinyl Pyrrolidine (PVP), Sodium Croscarmellose, Silicon Dioxide, Magnesium Stearate. Coating: HPMC, Titanium Dioxide, PVP. (For allergens see ingredients in bold)

Recommended Dosage:

1 Tablet Twice Daily.

Description:

Glucosamine not only helps ease joint discomfort but also may help improve the structure of joints

Glucosamine sulphate is a chemical found in the human body. It is used by the body to produce a variety of other chemicals that are involved in building tendons, ligaments, cartilage, and the thick fluid that surrounds joints. Joints are cushioned by the fluid and cartilage that surround them.

Product Information:

Millions of people take Glucosamine every day. Not surprisingly, this pure Glucosamine Sulphate remains one of our top selling glucosamine products and the best value for genuinely UK-made tablets.

The tablets have been designed to make them easy to swallow and the soluble taste-free coating keeps them fresh. We take great care by carefully formulating them and rigorously testing them to ensure they dissolve within just 30-60 minutes of swallowing, giving the glucosamine the maximum chance to be absorbed.

Reviews

There are no reviews yet.

Be the first to review “Premium – High Strength Quality Glucosamine Sulphate 2KCL Tablets – 1000mg x 90”

Your email address will not be published. Required fields are marked *